Cisplatin dose adjustment in patients with renal impairment, which recommendations should we follow?
about
Repeated administration of low-dose cisplatin in mice induces fibrosis.Discrepancies between the Cockcroft-Gault and Chronic Kidney Disease Epidemiology (CKD-EPI) Equations: Implications for Refining Drug Dosage Adjustment Strategies.Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety.Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin.Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review
P2860
Cisplatin dose adjustment in patients with renal impairment, which recommendations should we follow?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Cisplatin dose adjustment in p ...... ommendations should we follow?
@en
Cisplatin dose adjustment in p ...... ommendations should we follow?
@nl
type
label
Cisplatin dose adjustment in p ...... ommendations should we follow?
@en
Cisplatin dose adjustment in p ...... ommendations should we follow?
@nl
prefLabel
Cisplatin dose adjustment in p ...... ommendations should we follow?
@en
Cisplatin dose adjustment in p ...... ommendations should we follow?
@nl
P2093
P2860
P1476
Cisplatin dose adjustment in p ...... ommendations should we follow?
@en
P2093
Amandine Savry
Bertrand Pourroy
Laurence Gauthier-Villano
Magali Rocca
Pascale Pisano
P2860
P2888
P304
P356
10.1007/S11096-013-9912-7
P577
2014-01-17T00:00:00Z